KYN pathway activation, presented as IDO induction, and high serum KYN, KYNA, and QA levels correlate with CKD severity and inflammatory parameters, high-sensitivity C-reactive protein (hsCRP), and soluble TNF-receptor-1 (sTNFR-1) concentration, independently of serum creatinine level [63]. Here, IDO1 is linked to chronic kidney disease.